AnaptysBio, Inc. (ANAB)
44.79
+0.99
(+2.26%)
USD |
NASDAQ |
Dec 10, 14:04
AnaptysBio Total Assets (Quarterly): 353.10M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Ovid Therapeutics, Inc. | 63.85M |
| Ionis Pharmaceuticals, Inc. | 3.033B |
| Vanda Pharmaceuticals, Inc. | 601.14M |
| CorMedix, Inc. | 750.86M |
| Verastem, Inc. | 176.85M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 382.51M |
| Shareholders Equity (Quarterly) | -29.42M |
| Debt to Equity Ratio | -11.78 |
| Current Ratio | 8.678 |
| Net Debt Paydown Yield | 0.77% |